Skip to main content
. 1999 Jul 6;96(14):8126–8131. doi: 10.1073/pnas.96.14.8126

Table 3.

Hematopoietic reconstitution by NA cells from LTBMC

Cell source Weeks after transplant
3 6 12 24
Two-month LTBMC
 Fresh marrow 86  ± 8.4 (3/3) 61.7  ± 14.0 (3/3) 61.6  ± 15.0 (3/3) 67.2  ± 4.7 (3/3)
 Control LTBMC 22.7  ± 7.7 (4/4) 7.3  ± 2.9 (3/3) 1.7  ± 1.5 (4/4) 0.58  ± 0.57 (2/4)
 TPO-LTBMC 94.0  ± 4.8 (3/3) 70.4  ± 15.6 (3/3) 62.1  ± 20.5 (3/3) 53.7  ± 32.5 (3/3)
Three-month TPO-LTBMC
 25,000 4.7  ± 5.4 (3/4) 0.8  ± 1.6 (1/4) 0.8  ± 1.6 (1/4) 0.5  ± 1.0 (1/4)
 50,000 11.5  ± 8.6 (2/2) 12.3  ± 7.1 (2/2) 9.0* 43.6*
 100,000 39.0  ± 11.0 (3/3) 34.4  ± 15.0 (3/3) 26.2  ± 4.1 (3/3) 17.4  ± 5.4 (3/3)
 200,000 38.9  ± 9.1 (3/3) 29.2  ± 14.4 (3/3) 41.4  ± 36.3 (3/3) 36.7  ± 41.7 (3/3)
Four-month TPO-LTBMC
 100,000 14.9  ± 3.3 (4/4) 3.4  ± 2.4 (4/4) 1.8  ± 2.0 (4/4) 0.7  ± 1.2 (1/4)
 500,000 30.0  ± 17.5 (5/5) 10.3  ± 1.9 (5/5) 5.6  ± 1.4 (5/5) 3.4  ± 1.4 (5/5)

Numbers indicate the percent (±1 SD) CD45.1+ peripheral blood leukocytes. Numbers in parentheses indicate the number of positive animals (>0.5% CD45.1+)/number transplanted. 

*

Only one animal analyzed. 

Data are pooled from two experiments, with either 5.5 × 105 or 1.3 × 106 cells transplanted per animal. 

Number of NA cells transplanted per animal.